David Hubbard MD

 David Hubbard Jr., MD

David Hubbard Jr., MD


Current Positions

  • CEO, FANTAB, Inc. an fMRI neuropsychological testing company.
  • Chairman, Hubbard Foundation, a charitable foundation supporting research in applied neurophysiology and neurovascular diseases, San Diego, CA.
  • Director, Applied Functional MRI Institute, LLC, San Diego, CA.
  • Research Professor, California School of Professional Psychology, Alliant International University, San Diego, CA.
  • Founding board member, International Society for Neurovascular Disease
  • Associate Clinical Professor of Neurology, retired, University of California, San Diego
  • Adjunct professor of psychology, San Diego State University
  • Founder, MindSign Neuromarketing, LLC, San Diego, CA.


  • CHIEF RESIDENT, NEUROLOGY, Albert Einstein College of Medicine, Bronx, NY, 1980-1981.
  • RESIDENT, NEUROLOGY, Albert Einstein College of Medicine, Bronx, NY, 1978-1980.
  • INTERN, MEDICINE, Waterbury Hospital - Yale University, 1977-1978.
  • M.D., University of Connecticut School of Medicine, 1977.
  • M.A., COUNSELING PSYCHOLOGY, Stanford University, 1971.
  • B.A., PHILOSOPHY, Yale University, 1970. Phillips Exeter Academy, 1963-1966

Board Certification

DIPLOMATE IN NEUROLOGY, American Board of Neurology and Psychiatry, 1984.

Medical Licenses

California G50317
New York 141424


  • International Society for Neurovascular Diseases
  • American Academy of Neurology


  • Scholastic Excellence Award, University of Connecticut School of Medicine, 1977.
  • “Beyond the Call of Duty” Award, Scripps Memorial Hospital, La Jolla, California, March 1990.


Hampshire A, Owens A, Hubbard D. fMRI neuropsychological battery for athletes with concussion. Am Acad Neurology, Philadelphia, April 2014.

Hampshire A, MacDonald A, Owen A. Hypoconnectivity and Hyperfrontality in Retired American Football Players. Nature-Scientific Reports, 3, 2972, 2013.

Hubbard D, Ponec D, Gooding J, Saxon R, Sauder H, Haacke EM. Clinical improvement after extracranial venoplasty in multiple sclerosis. J Vasc Interv Radiol, 2012.

Haacke EM ... Hubbard D et al. Patients with multiple sclerosis with structural venous abnormalities on MR imaging exhibit an abnormal flow distribut ion of the internal jugular veins. J Vasc Interv Radiol 23:60-68, 2012

Feng W et al. Quantitative flow measurements in the internal jugular veins in patients with multiple sclerosis. Rev. Recent Clin Trials 7,117-126, 2012.

Oliveira A, Gevirtz G, Hubbard D. A psycho-educational video used in the emergency department provides effective treatment for whiplash injuries. Spine, 31,15,1652-1657, 2006.

Landis D, Hubbard D, Cua P, Walker D. Disease management of chronic pain improves employee productivity and lowers healthcare costs. Health & Productivity Management, 2,2, May 2003.

Hubbard D. Guidelines for Musculoskeletal and Chronic Pain, Breaking Down the Barriers of Pain. Practical Pain Management, Vol. 1-5, Jan-Sept, 2001.

Hubbard D. Persistent muscular pain: Approaches to relieving trigger points. J. Musculoskeletal Medicine 15, No. 5, 16-26, May, 1998.

Banks S et al. Effects of autogenic relaxation training on electromyographic activity in active trigger points. J Musculoskeletal Pain 6,4,23-32. 1998.

Gerwin R, Shannon S, Hong C, Hubbard D, Gevirtz R. Interrater reliability in myofascial trigger points. Pain 69,1-2,65-73, 1997.

Hubbard D. Chronic and recurrent muscle pain: pathophysiology, treatment and review of pharmacologic studies. J. Musculoskeletal Pain 4,1/2,123-143, 1996.

Gevirtz R, Hubbard D, Harpin R. Psychophysiologic treatment of chronic lower back pain. Professional Psychology: Research and Practice 27,6,561-566, 1996.

Hubbard D. Getting Tension. Biofeedback Newsletter, 1, 14-16, 1996.

Lewis C, Gevirtz R, Hubbard D, Berkoff G. Needle trigger point and surface frontal EMG measurements of psychophysicological responses in tension-type headache patients. Biofeedback & Self-Regulation 19, 3, 274-275, 1994.

McNulty W, Gevirtz R, Berkoff G, Hubbard D. Needle electromyographic evaluation of trigger point response to a psychological stressor, Psychophysiology, 31, 313-316, 1994.

Hubbard D, Berkoff B. Myofascial trigger points show spontaneous needle EMG activity. Spine, 18, 13, 1803-1807, 1993.

Cady R, et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 265(21):2831-2835, 1985.

Hubbard D. Adrenocortical responsiveness: lack of correlation to life events, Type A trait or locus of control, Psychosom Med, 45, 1, 80, 1983.

Reinitz E, Hubbard D, Grayzel A. Central nervous system systemic lupus erythematosus vs. CNS infection; low CSF glucose and pleocytosis in a patient with a prolonged course, Arth Rheum, I25, 5, 583, 1982.

Hannum J, Thoresen C, Hubbard D. A behavioral study of self-esteem with elementary teachers. In Mahoney M, Thoresen C. (eds) Self-Control: Power to the Person, Monterey, Brooks/Cole, 1974.


Hubbard, David R.: Functional magnetic resonance imaging biomarker of neural abnormality. U.S. Patent Application published Sept. 18, 2014.

Hubbard, David R.: Methods to diagnosis and measure vascular drainage insufficiency in the central nervous system. U.S. Patent 8.571,634 B2, October 29, 2013.

Hubbard, David R: Pharmaceutical formulations of sympathetic antagonist for the treatment of chronic muscle pain. Filed February 17, 2006.

Hubbard, David R.: Multi-electrode and needle injection device for the diagnosis and treatment of muscle injury and pain, U.S. Patent No. 6,678,550 B2, Jan 13, 2004.

Hubbard, David R.: Multi-electrode and needle injection device for the diagnosis and treatment of muscle injury and pain, U.S. Patent No. 6,356,783 B1, Mar 12, 2002.

Hubbard, David R.: Multi-electrode and needle injection device for the diagnosis and treatment of muscle injury and pain, U.S. Patent No. 10/017,072, Dec 7, 2001.

Hubbard, David R. and Johnson, Paul. Methods and equipment for treating or preventing muscle pain or injury. Australian Patent No. 731029, July 5, 2001.

Hubbard, David R.: Methods and equipment for treating muscle injury and pain, U.S. Patent No. 6,155,994, Dec. 5, 2000.

Hubbard, David R: Use of sympathetic antagonists for treatment of chronic muscle pain, U.S. Patent No. 6,009,875, Jan. 4, 2000.

Hubbard, David R.: Multi-electrode and needle injection device for the diagnosis and treatment of muscle injury and pain, Intl Patent No. WO9822021, May 28, 1998.

Hubbard, David R.: Use of sympathetic blockade for treatment of chronic muscle pain, U.S. Patent No. 5,513,661, May 7, 1996.


  • Medical Expert, OneHealth.com , 2010-2014.
  • Medical Director, Musculoskeletal and Chronic Pain, CorSolutions Medical, Inc. Rosemont, Illinois, 2001-2006.
  • Consultant to HealthNet, Woodlawn, CA: "Guidelines To Appropriate Chronic Pain Management,” 2004.
  • Consultant to Schering-Berlex: FDA Phase 2 trial, “Phenoxybenzamine intramuscular injection for chronic myofascial pain. MyoLink and Schering-Berlex.
  • Medical Director, MyoPoint Pain Management Medical Group, San Diego, CA, 1997-2001.
  • Medical Director, Sharp Pain Rehabilitation Services, Sharp HealthCare, San Diego, CA, 1992-1998.
  • Associate Clinical Professor, Pain Neurology Residents Clinic, University of California, San Diego, 1983-2000.
  • Principal investigator, Phase III Clinical trials of sumatriptan, 1989-1993.
  • Co-Founder and Chairman of the Board, Country Montessori School Poway, CA. 1987-1994.
  • FDA Phase III Clinical Trial of nimodipine in Migraine, 1985-1986.
  • Instructor of Neurology, Departments of Psychiatry and Neurology, Cornell Medical Center, New York Hospital, Westchester Division, 1982-1983.
  • Instructor of Neurology, Department of Neurology, Albert Einstein College of Medicine, Montefiore Hospital, 1981-1982.
  • Attending and Supervisor of Biofeedback, Montefiore Headache
  • and Pain Unit, 1978-1983.
  • Director, Clinical Evoked Potential Laboratory, Department
  • of Neurology, Montefiore Medical
  • Center, Albert Einstein College of Medicine, 1979-1982.
  • Neurology Consultant, Center for Neuropsychological Services, Monte
  • fiore Medical Center,
  • 1981-1982.
  • Extern, Aphasia Research Unit, D. Frank Benson, M.D., Director, Boston VA Hospital, Boston
  • University School of Medicine, 1976.
  • Extern, Maida Vale Hospital and Queens Square Hospital, London, 1974.
  • Extern, Psychophysiology Clinic, Charles Stroebel, Ph.D., M.D., Director, Institute of Living, Hartford, Connecticut, 1975.
  • Neurochemistry Laboratory, Jack Barchas, M.D., Director, Stanford University School of Medicine, 1974.
  • Stanford Center for Research and Development in Teaching, 1971-1973.


Married to Arlene P. Hubbard, OTR, MA Counseling Psychology; since 1980, children Devin P Hubbard born 1982, and Alexandra W Hubbard, born 1984. Home in Poway, CA since 1987.